Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

12/8/2013 (4 months ago)

Catholic Online (www.catholic.org)

Drug will make treating the condition faster and easier

Called sofosbuvir, and produced by Gilead Sciences Inc., liver specialists are now recommending this new medicine for chronic hepatitis C. Sofosbuvir can be paired with other drugs to make treatment of the debilitating disease faster, easier and more effective. Sofosbuvir won approval from the Food and Drug Administration last week.

Called sofosbuvir, and produced by Gilead Sciences Inc., liver specialists are now recommending this new medicine for chronic hepatitis C.

Called sofosbuvir, and produced by Gilead Sciences Inc., liver specialists are now recommending this new medicine for chronic hepatitis C.

Article Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

12/8/2013 (4 months ago)

Published in Health

Keywords: Hepatitis C, interferon, study, sofosbuvir, rivavirin


LOS ANGELES, CA (Catholic Online) - Hailed as part of a "revolution in treatment," David Thomas, a liver specialist at Johns Hopkins Medical Institutions, Baltimore says. He adds that the "upshot is that over the next year to the next 18 months there will be a series of medications approved that will vastly simplify the treatment of hepatitis C for nearly everyone and increase the cure rate beyond 90 percent."

A deadly and sometimes fatal ailment, more than three million people in the united States are infected with the hepatitis C virus. Many have no symptoms until their livers begin to fail, causing jaundice, fatigue and other problems. Hepatitis C remains the nation's leading cause of liver cancer and liver transplants. 

Up until now, standard three-drug treatments have taken 24 to 48 weeks and required self-injections of interferon. That drug at times can cause irritating flu-like symptoms and mood swings.

Under the brand name Sovaldi, Sofosbuvir will be the first treatment that some patients will be able to take for just 12 weeks with just one additional drug and no interferon.

The FDA approved the no-interferon combination for patients with two strains of the virus, genotypes 2 and 3. Patients with a more common strain, genotype 1, sofosbuvir is approved to be taken with interferon and an older drug called ribavirin.

There are the expected catches. Some patients still will have to be treated for 24 weeks - and none of the regimens are 100 percent effective.

In one study, 89 percent of genotype 1 patients who took the three-drug version were cured in 12 weeks, compared with 75 percent cured in longer-lasting available regimens.

Sofosbuvir does not add any obvious side effects to those already associated with the drugs it is paired with, Ira Jacobson, a liver specialist at Weill Cornell Medical College, New York says. Jacobson has led drug studies for Gilead.

As a result, patients taking it with ribavirin may experience fatigue and insomnia and those who also take interferon will have additional side effects, but for a shorter time than in the past, Jacobson says.

It comes at a substantial cost. The wholesale cost for a one-month supply of Solvadi will be $28,000, Gilead said in a press release.

A birth foretold: click here to learn more!

---


Pope Francis: end world hunger through 'Prayer and Action'


2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for April 2014
Ecology and Justice:
That governments may foster the protection of creation and the just distribution of natural resources.
Hope for the Sick: That the Risen Lord may fill with hope the hearts of those who are being tested by pain and sickness.



Comments


More Health

DEADLY BACTERIA: Dreaded MRSA virus now infecting U.S. homes Watch

Image of Bedding, clothes and other everyday surfaces used by someone affected by MRSA are suggested to be cleaned by bleach and hot water.

By Catholic Online (NEWS CONSORTIUM)

The anti-biotic resistant "superbug" known as methicillin-resistant Staphylococcus aureus, or MRSA for short, is a deadly drug-resistant virus that plagues mostly hospitals. A new report has found that virus can now incubate in private residences, meaning that ... continue reading


WHICH IS WORSE? 'I'd rather have HIV than diabetes,' one controversial doctor says Watch

Image of Dr. Max Pemberton say that it is now very rare for someone to die of HIV in the U.K. and that, in fact, people with the virus have a very similar life expectancy to people who are HIV-negative.

By Catholic Online (NEWS CONSORTIUM)

At one time, HIV and AIDS was considered a horrifying death sentence. There was no way to control it, and those who suffered from it would suffer, long painful deaths as their faculties fell away. Diabetes, on the other hand, was a given for those who ... continue reading


Death lurks about the cutting board: Kitchens could be sources of drug-resistant bacteria, experts warn Watch

Image of Ironically, the cutting board -- and NOT the knife, represents the greatest threat to health and safety, experts say.

By Catholic Online (NEWS CONSORTIUM)

There's a killer lurking undetected in many ordinary kitchens, experts warn. Cutting boards used to prepare raw poultry may be an important source of drug-resistant bacteria in both hospital kitchens and private homes, a new study warns. LOS ANGELES, CA ... continue reading


Uh-oh! One in every 20 adults seeking medical care walks away misdiagnosed Watch

Image of In little more than five percent of cases, the original diagnosis was wrong and could have been accurately detected by the information available in the first setting.

By Catholic Online (NEWS CONSORTIUM)

If you're diligent and go to your doctor regularly - you still may not be getting a clean bill of health. According to a new study, one in 20 Americans who see their doctor may walk away having their condition misdiagnosed. Twelve million Americans a year could ... continue reading


Analysis: Millions wasted on shoddy flu drug, Tamiflu Watch

Image of The analysis, from the Cochrane Collaboration claims Tamiflu did not prevent the spread of flu or reduce dangerous complications.

By Catholic Online (NEWS CONSORTIUM)

It's an especially harsh analysis for a drug that many people keep in their bathroom mirror for a sudden outbreak of the sniffles. A new analysis says that many millions may have been wasted on Tamiflu, a common drug used to treat flu symptoms. According to the ... continue reading


Deadly H5N1 bird flu virus could easily mutate to spread from human to human Watch

Image of When the healthy ferret developed flu symptoms, such as ruffled fur, loss of appetite and lack of energy - researchers knew the virus had spread through the air.

By Catholic Online (NEWS CONSORTIUM)

The avian flu, or H5N1 virus was so deadly scientists once halted research as governments feared it might be used by terrorists to stage a biological attack. The dreaded H5N1 avian influenza has since killed 60 percent of the 650 humans known to be infected ... continue reading


Scottish scientists successfully regenerate organ in mouse - could humans be next? Watch

Image of After the regeneration, the treated mice also started to make more T-cells, which is a type of white blood cell key to fighting infections.

By Catholic Online (NEWS CONSORTIUM)

A breakthrough which may pave the way for the technique to be used in humans has been uncovered by Scottish scientists. Researchers have been able to fully restore an organ in a living animal for the first time.  LOS ANGELES, CA (Catholic Online) - The team ... continue reading


New drug used to treat breast cancer heralded as 'quite groundbreaking' Watch

Image of While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

By Catholic Online (NEWS CONSORTIUM)

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a ... continue reading


Delicious Earl Grey tea found to have hidden health benefit Watch

Image of Bergamot is a Mediterranean citrus fruit which gives Earl Grey its distinct taste and smell. It has enjoyed popularity among the upper and middle classes.

By Catholic Online (NEWS CONSORTIUM)

Many drink it for its taste and the enjoyment it brings, without thought of it being "good for them." Scientists now say that Earl Grey tea can lower cholesterol and reduce the chances of heart disease. LOS ANGELES, CA (Catholic Online) - A popular beverage ... continue reading


Deaf since birth, woman hears - for the first time Watch

Image of Deaf since birth, 40-year-old Joanne Milne received cochlear implants - and is now learning to hear the world for the very first time. Electronic implants were switched on, and Milne burst into tears when the sound of a nurse reciting the days of the week gave her the first sensation of sound.

By Catholic Online (NEWS CONSORTIUM)

Deaf since birth, 40-year-old Joanne Milne received cochlear implants - and is now learning to hear the world for the very first time. Electronic implants were switched on, and Milne burst into tears when the sound of a nurse reciting the days of the week gave ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Acts 3:11-26
11 Everyone came running towards them in great ... Read More

Psalm, Psalms 8:2, 5, 6-7, 8-9
2 even through the mouths of children, or of babes in ... Read More

Gospel, Luke 24:35-48
35 Then they told their story of what had happened on ... Read More

Saint of the Day

Saint of the Day for April 24th, 2014 Image

St. Fidelis of Sigmaringen
April 24: Franciscan Capuchin martyr. He was born Mark Rey is Sigmaringen, ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter